Business Leaders

Latest NewsCompaniesMarketsEconomy & ForexCommoditiesInterest RatesBusiness LeadersFinance Pro.CalendarSectors 
HomeAll NewsMost read newsBusiness Leaders Biography
Portrait de Rita Karachun
Age : 60
Public asset : 3,645,425 USD
Country of residence : Unknown
Linked companies : Merck & Co., Inc. - Acceleron Pharma Inc. - ArQule, Inc. - Immune Design Corp

Summary 
Rita A. Karachun is a businessperson who has been at the head of 5 different companies. Presently, she is Senior Vice President-Finance & Global Controller at Merck & Co., Inc. and Chief Executive Officer & Director at Immune Design Corp., President & Director at ArQule, Inc., President at Acceleron Pharma, Inc. and President & Director at GlycoFi, Inc. (which are all subsidiaries of Merck & Co., Inc.).

In her past career Rita A. Karachun occupied the position of President for Inspire Pharmaceuticals, Inc.




Current positions of Rita Karachun 
Holdings of Rita Karachun 
Rita Karachun : Personal Network 
Most Read News 
05/11CATHIE WOOD : Tumble in Coinbase pushes Wood's ARK fund closer to pandemic low
RE
05/02ELON MUSK : Musk seeks to put in less money in new Twitter deal financing -sources
RE
05/14ELON MUSK : Elon Musk says Twitter legal team told him he violated an NDA
RE
05/11ELON MUSK : Musk's delay in disclosing Twitter stake triggers SEC probe - WSJ
RE
05/05LARRY ELLISON : Musk to lead Twitter temporarily after $44 billion takeover - source
RE
05/12MASAYOSHI SON : SoftBank Vision Fund posts $26 billion loss; Son pledges defence
RE
05/03Stocks rise, U.S. yields slip as markets await Fed rate hike
RE
05/04WARREN BUFFETT : Berkshire shareholders overwhelmingly vote to keep Buffett chairman
RE
05/03ELON MUSK : Elon Musk plans to take Twitter public again later - WSJ
RE
05/05JACK DORSEY : Dorsey-led Block beats operating profit estimates, shares surge 10%
RE
More news


© 2022 People and Ownership :   
Rita Karachun : Connections 


Latest news about Rita Karachun 
2021Organon & Co. Announces Executive Changes
CI
2020ArQule, Inc. Announces Management Changes
CI
2018TRANSCRIPT : Merck & Co., Inc. - Shareholder/Analyst Call
CI
2017TRANSCRIPT : Merck & Co., Inc. - Shareholder/Analyst Call
CI
2016TRANSCRIPT : Merck & Co. Inc. - Shareholder/Analyst Call
CI
2015TRANSCRIPT : Merck & Co. Inc. - Shareholder/Analyst Call
CI
2014TRANSCRIPT : Merck & Co. Inc. - Shareholder/Analyst Call
CI
More news